Screening children with NF1 for optic pathway glioma-Yes

Eye

Volumn 24, Issue 9, 2010, Pages

  Simmons, I ^a   Gogi, D ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ERLOTINIB; EVEROLIMUS; RAPAMYCIN;

ASTROCYTOMA; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RESEARCH; CANCER SCREENING; CANCER SUSCEPTIBILITY; CHILD; CLINICAL TRIAL; EYE EXAMINATION; GENOTOXICITY; HUMAN; NEUROFIBROMATOSIS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NERVE GLIOMA; PATIENT SAFETY; VISION TEST; VISUAL ACUITY;

EID: 77956609397     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.93     Document Type: Note

References (21)

1. Parsa C.F., Givrad S. Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas
2. Listernick R., Ferner R.E., Liu G.T., Gutmann D.H. Optic pathway gliomas in neurofibromatosis 1: controversies and recommendations
3. Hersh J.H. Health supervision for children with neurofibromatosis. Pediatrics 2008; 121: 633–642.
4. Study of the natural history of neurofibromatosis 1. National Cancer Institute
5. Multicentre study for children and adolescents with low grade glioma
6. Hegedus B., Hughes F.W., Garbow J.R., Gianino S., Banerjee D.,Kim K.,Ellisman M.H.,Brantley Jr M.A.,Gutmann D.H.Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.Journal of Neuropathology and Experimental Neurology 68(5),2009.pp:542-551
7. Hegedus B.,Banerjee D.,Yeh T.-H.,Rothermich S.,Perry A.,Rubin J.B.,Garbow J.R.,Gutmann D.H.Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.Cancer Research 68(5),2008,pp:1520-1528
8. Blazo M.A., Lewis R.A., Chintagumpala M.M., Frazier M.,McCluggage C., Plon S.E. Outcomes of systematic screening for optic pathway tumours in children with neurofibromatosis 1.American Journal of Medical Genetics 127(3),2004.pp:224-229
9. Chang B.C.M., Mirabella G., Yagev R., Banh M., Mezer E.,Parkin P.C.,Westall C.A.,Buncic J.R.Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type1 by using sweep visual evoked potentials.Investigative Ophthalmology and Visual Science 48(6),2007.pp:2895-2902
10. Wolsey D.H., Larson S.A., Creel D., Hoffman R.Can Screening for Optic Nerve Gliomas in Patients With Neurofibromatosis Type I Be Performed With Visual-Evoked Potential Testing?.Journal of AAPOS 10(4),2006.pp:307-311.
11. Hottinger A.F., Yoon H., DeAngelis L.M., Abrey L.E.Neurological outcome of long-term glioblastoma survivors.Journal of Neuro-Oncology 95(3),2009.pp:301-305
12. Lama G.,Esposito S.M.,Grassia C.,Calabrese E.,Grassia M.G.,Bismuto R.,Melone M.A.,Russo S.,Scuotto A.Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up.Minerva Pediatrica 59(1),2007.pp:13-21
13. Thiagalingam S.,Flaherty M.,Billson F.,North K.Neurofibromatosis type 1 and optic pathway gliomas: Follow-up of 54 patients.Ophthalmology 111(3),2004.pp:568-577
14. Via P.D.,Opocher E.,Pinello M.L.,Calderone M.,Viscardi E.,Clementi M.Battistella P.A.,Laverda A.M.,Dalt L.D.,Perilongo G.Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.Neuro-Oncology 9(4),2007.pp:430-437
15. Phase II trial of RAD001 in patients with low grade glioma
16. A phase I/II trial of a new tyrosine kinase inhibitor(Tarceva) during and after radiotherapy in the treatment of patients with newly diagnosed high grade glioma and unfavourable low-grade glioma
17. Tarceva/rapamycin for children with low-grade gliomas with or without Neurofibromatosis type1.
18. Franz D.N., Leonard J., Tudor C., Chuck G., Care M.,Sethuraman G.,Dinopoulos A.,Thomas G.,Crone K.R.Rapamycin causes regression of astrocytomas in tuberous sclerosis complex.Annals of Neurology 59(3),2006.pp:490-498.
19. Lacaze E., Kieffer V., Steri A., Lorenzi C., Gentaz E., Habrand J.L.,Dellatolas G.,Kalifa C.,Grill J.Neuropsychological outcome in children with optic pathway tumours when first line treatment is chemotherapy.British Journal of Cancer 89(11),2003.pp:2038-2044.
20. Grill J., Couanet D.,Cappelli C.,Habrand J.L., Rodriguez D.,Sainte-Rose C.,Kalifa C.Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma.Annals of Neurology 45(3),1999.pp:393-396
21. A phase II study of conformal radiotherapy in patients with low grade glioma